Drug updated on 11/14/2023
|Injection (subcutaneous: 3120 mcg/1.56 mL)
|Human parathyroid hormone related peptide analogs
| Ongoing and
- For the treatment of postmenopausal women with osteoporosis at high risk for fracture.
Product Monograph / Prescribing Information
|Tymlos (abaloparatide) Prescribing Information.
|Radius Health, Inc., Waltham, MA
Systematic Reviews / Meta-Analyses
Clinical Practice Guidelines
|American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2020 update.
|Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline.
|The Journal of Clinical Endocrinology & Metabolism